A review is given of common pharmacological therapies for Menière's disease. The use of vasodilators and hyperosmotic agents is discussed on the bases of clinical and experimental investigations. Osmotic reduction of intralabyrinthine water seems to play a major role in the induced hearing gain but positive effects on the inner ear blood flow cannot be excluded.
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/02/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/3554484